PFIZER INC — Director's Dealing 2025

Apr 28, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PFIZER INC (PFE)
CIK: 0000078003
Period of Report: 2025-04-24

Reporting Person: BLAYLOCK RONALD E (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2025-04-24	Phantom Stock Units	$	A	8999.0000	Acquired		Common Stock (8999.0000)	Direct

Footnotes

F1: Each unit represents one phantom share of common stock.

F2: Granted pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Unit Award Plan for Non-Employee Directors.

F3: These units represent deferred director's compensation that are settled in cash or common stock at the director's election following the reporting person's retirement from the Board of Directors.